By: Eric M. Strauss, Youri Benadjaoud, Mary Kekatos
The vaccine, mFLUSIVA, is expected to be available for people 50 and older for the 2026-2027 respiratory illness season.
United States (National)
Mary Kekatos
Geo Focus
Coverage Attributes:
Beta
Informative:
54
%
Data Driven:
32
%
Events:
6
%
Interviews Q&as:
5
%
Promotional:
1
%
Themes Covered:
Not enough data
Pitching Insights
Mary Kekatos covers a wide range of health-related topics, including public health, medical breakthroughs, legal issues, and natural disasters. Her coverage attributes indicate a reliance on data and government announcements as sources for her reporting.
To effectively reach out to Mary, consider offering factual insights backed by robust data or referencing official government statements related to healthcare policies or public health crises. Topics such as medical breakthroughs or legal developments in the healthcare sector would also be relevant for her coverage.
Given the national focus without specification of location within the United States, pitches should keep this broad geographic scope in mind when providing context or relevance.
This information evolves through artificial intelligence and human feedback. Improve this profile .
Journalists With Similar Coverage:
Based on similarity of content.
Publications
Most recent topics
Not enough data
Publications
Most recent topics
Not enough data
Publications
Most recent topics
Not enough data
Publications
Most recent topics
Not enough data
Publications
Most recent topics
Not enough data
Publications
Most recent topics
Not enough data
